跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺和锐30 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Insulin Aspart 30 Injection
Approved
生物制品
Insulin Aspart 30 Injection
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Aug 8, 2019
Approval ID
7MazXbP99xY
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
7MazXbP99xY
Approval Number
S20140058
Generic Name
门冬胰岛素30注射液
Generic Name En
Insulin Aspart 30 Injection
Trade Name
诺和锐30
Drug Type
生物制品
Dosage Form
注射剂
Strength
100单位/毫升,3毫升/支(笔芯)
Reg Date
2019-08-08
Expired Date
2024-08-07
Company Name
Novo Nordisk A/S
Company Address
Novo Alle, DK-2880 Bagsvaerd, Denmark
Production Company Name
Novo Nordisk A/S
Production Company Address
Novo Alle, DK-2880 Bagsvaerd
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 8, 2019
Approval ID
7MazXbP99xY
Type
生物制品
Back to NMPA Approvals